EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Randomized control trial of moderate dose vitamin D alters microbiota stability and metabolite networks in healthy adults

Madhur Wyatt iD, Ankan Choudhury, Gabriella Von Dohlen, Jeffery L Heileson, Jeffrey S Forsse, Sumudu Rajakaruna, Manja Zec, Malak M Tfaily, Leigh Greathouse iD

Microbiology Spectrum · 2024

DOI: 10.1128/spectrum.00083-24 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Microbiology Spectrum, 2024. Verfasst von Madhur Wyatt und 8 weiteren Autor:innen. Beteiligte Einrichtung: Human Health Performance and Recreation, Robbins College of Health and Human Sciences, Baylor University, Waco, Texas, USA. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Vitamin D, Dietary Supplements. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 104 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: U.S. Department of Energy (DOE), Baylor University (BU).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Evidence indicates that both vitamin D and the gut microbiome are involved in the process of colon carcinogenesis. However, it is unclear what effects supplemental vitamin D 3 has on the gut microbiome and its metabolites in healthy adults. We conducted a double-blind, randomized, placebo-controlled trial to identify the acute and long-term microbiota structural and metabolite changes that occur in response to a moderate dose (4,000 IU) of vitamin D 3 for 12 weeks in healthy adults. Our results demonstrated a significant increase in serum 25-hydroxy-vitamin D (25(OH)D) in the treatment group compared to placebo ( P < 0.0001). Vitamin D 3 significantly increased compositional similarity ( P < 0.0001) in the treatment group, and enriched members of the Bifidobacteriaceae family. We also identified a significant inverse relationship between the percent change in serum 25(OH)D and microbial stability in the treatment group ( R = −0.52, P < 0.019). Furthermore, vitamin D 3 supplementation resulted in notable metabolic shifts, in addition to resulting in a drastic rewiring of key gut microbial-metabolic associations. In conclusion, we show that a moderate dose of vitamin D 3 among healthy adults has unique acute and persistent effects on the fecal microbiota, and suggest novel mechanisms by which vitamin D may affect the host-microbiota relationship. IMPORTANCE Preventative measures to reduce the rise in early-onset colorectal cancer are of critical need. Both vitamin D, dietary and serum levels, and the gut microbiome are implicated in the etiology of colorectal cancer. By understanding the intimate relationship between vitamin D, the gut microbiome, and its metabolites, we may be able to identify key mechanisms that can be targeted for intervention, including inflammation and metabolic dysfunction. Furthermore, the similarity of vitamin D to cholesterol, which is metabolized by the gut microbiome, gives precedence to its ability to produce metabolites that can be further studied and leveraged for controlling colorectal cancer incidence and mortality.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal MicrobiomeVitamin DDietary SupplementsHumansAdultMaleFemaleDouble-Blind MethodMiddle AgedHealthy VolunteersYoung AdultCholecalciferolBacteriaFeces

Stichwörter der Autor:innen

colon cancerearly-onset colorectal cancergut microbiomeinflammationmicrobiome stabilityvitamin D

Substanzen

Vitamin D25-hydroxyvitamin DCholecalciferol

Autor:innen und Institutionen

  • Human Health Performance and Recreation, Robbins College of Health and Human Sciences, Baylor University, Waco, Texas, USA.
  • Human Science and Design, Robbins College of Health and Human Sciences, Baylor University, Waco, Texas, USA.
  • Nutrition Services Division, Walter Reed National Military Medical Center, Bethesda, Maryland, USA.
  • Department of Biology, Baylor University, Waco, Texas, USA.
  • Department of Environmental Science, University of Arizona, Tucson, Arizona, USA.
  • BIO5 Institute, The University of Arizona, Tucson, Arizona, USA.

ORCID-Profile: Madhur Wyatt, Leigh Greathouse

Förderung

  • U.S. Department of Energy (DOE)
  • Baylor University (BU)

Zitieren

APA

Wyatt, M., Choudhury, A., Von Dohlen, G., Heileson, J. L., Forsse, J. S., Rajakaruna, S., Zec, M., Tfaily, M. M., & Greathouse, L. (2024). Randomized control trial of moderate dose vitamin D alters microbiota stability and metabolite networks in healthy adults. Microbiology Spectrum. https://doi.org/10.1128/spectrum.00083-24

Vancouver

Wyatt M, Choudhury A, Von Dohlen G, Heileson JL, Forsse JS, Rajakaruna S, et al. Randomized control trial of moderate dose vitamin D alters microbiota stability and metabolite networks in healthy adults. Microbiology Spectrum. 2024. doi:10.1128/spectrum.00083-24

BibTeX
@article{Wyatt2024,
  author = {Wyatt, Madhur and Choudhury, Ankan and Von Dohlen, Gabriella and Heileson, Jeffery L and Forsse, Jeffrey S and Rajakaruna, Sumudu and Zec, Manja and Tfaily, Malak M and Greathouse, Leigh},
  title = {Randomized control trial of moderate dose vitamin D alters microbiota stability and metabolite networks in healthy adults},
  journal = {Microbiology Spectrum},
  year = {2024},
  doi = {10.1128/spectrum.00083-24}
}
Kostenlos starten →